ProShares - UltraShort Nasdaq Biotechnology (BIS) |
| 10.956 -0.431 (-3.79%) 10-27 16:00 |
| Open: | 11.585 |
| High: | 11.6 |
| Low: | 10.95 |
| Volume: | 10,482 |
| Market Cap: | 2(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Leveraged |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 12.63 |
| Resistance 1: | 11.95 |
| Pivot price: | 11.62 |
| Support 1: | 10.85 |
| Support 2: | 9.03 |
| 52w High: | 22.98 |
| 52w Low: | 10.51 |
The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 23 Oct 2026
What Is Behind the 3% Gain in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) as Large Biotechs Ease? - kalkine.ca
Mon, 11 May 2026
ProShares Announces ETF Share Splits - Business Wire
Wed, 14 May 2025
Top Performing Leveraged/Inverse ETFs: 05/11/2025 - ETF Database
Tue, 19 Nov 2024
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Database
Wed, 22 Mar 2023
Healthcare Stocks List: Top Healthcare Companies & ETFs - Bullish Bears
Mon, 05 Dec 2022
3 “Oversold” ETFs to Start the Week - ETF Database
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
